First Ascent Biomedical raised $6M in an angel investment led by Vidal Duart Enterprises, Inc. to revolutionize cancer treatment with personalized technology.

Jan 13, 2025•8 months ago

Amount Raised

$6 Million

MiamiTherapeuticsMedicalBiotechnologyHealth Care

Investors

TechstarsVidal Duart Enterprises, Inc.

Description

First Ascent Biomedical has secured a $6 million investment from Vidal Duart Enterprises, Inc., along with co-investment from Techstars. The funding will be used to enhance operations and establish a state-of-the-art lab in Florida, focusing on personalized cancer treatment technologies.

Company Information

Company

First Ascent Biomedical

Location

Miami, Florida, United States

About

First Ascent Biomedical is a leader in Functional Precision Medicine, leveraging advanced technologies to personalize cancer treatment. The company focuses on personalized cancer care with their innovative platform that integrates drug testing, DNA/RNA sequencing, and AI-guided tumor weakness mapping. Their technology aims to improve patient survival by moving away from one-size-fits-all approaches and providing tailored treatment strategies. They are committed to making cancer care widely accessible, especially for underserved communities.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns